Monthly Newsletter from the Arizona Asthma Coalition |
|
|
Improved Clinical Outcomes in Patients With Severe Asthma Treated With Biologic Therapies
American Journal of Managed Care
Patients with severe asthma treated with either omalizumab, benralizumab, or mepolizumab achieved improved clinical outcomes after 12 months, with the rate of complete responders increasing at the end of long-term follow-up. |
|
|
|
|
Trials show asthma drug helps reduce allergic reactions to certain foods
PBS NewsHour
There's some relief for people with food severe allergies. A study published in the New England Journal of Medicine reports the drug Xolair allows people with allergies to tolerate higher doses of allergenic foods before developing a reaction after accidental exposure. Geoff Bennett discussed more with the study’s principal investigator, Dr. Robert Wood of the Johns Hopkins Children’s Center. |
|
|
|
|
Air pollution, socioeconomic disadvantages may increase children’s risk of asthma
Harvard School of Public Health
Early life exposure to air pollution may increase the risk of developing asthma by early or middle childhood—especially among socioeconomically disadvantaged children, according to a new study co-authored by Harvard T.H. Chan School of Public Health.
|
|
|
|
|
10,000 more kids to qualify for health care insurance
Arizona Capitol Times
Nearly 10,000 Arizona children of the working poor will soon be eligible for subsidized health care.The federal Centers for Medicare and Medicaid Services has approved a bid by the state to expand eligibility for its Kids Care program to 225% of the federal poverty level, up from 200%. That translates out to $58,895 for a family of three and $70,200 for a family of four, with higher levels for larger families.
With the new eligibility standards, that should boost enrollment to close to 72,000 youngsters. |
|
|
|
|
New York AG asks FDA to double down on warnings, discourage prescription for asthma drug
The Hill
The New York attorney general’s office is asking the Food and Drug Administration (FDA) to double down on its warnings and discourage the use of an asthma drug. |
|
|
|
|
LUNG FORCE Walk - Tucson
Saturday, May 4
The LUNG FORCE Walk is coming back to Tucson! Join us and turn small steps into bold strides toward a world without lung cancer and lung disease.
Come out and experience the celebratory and welcoming atmosphere of a LUNG FORCE event.
It doesn't matter how you roll, whether you like to saunter, power-walk or stroll. There's a Walk Your Way virtual option for those who can't make it to the event.
The LUNG FORCE Walk provides critical funds for lifesaving research, early detection initiatives, and awareness outreach to vulnerable communities.Register today and save your spot. |
|
|
|
|
The association between asthma and atrial fibrillation: systematic review and meta-analysis
Nature
Respiratory disease and atrial fibrillation (AF) frequent coexist, but the risk of AF among asthma patients is less characterized. Growing evidence suggest that AF shares with asthma a systemic inflammation background and asthma treatments, such as beta agonists, have been associated with increased risk of cardiac arrhythmias. |
|
|
|
|
Join the Arizona Asthma Coalition As a nonprofit partnership since 1996, AAC has worked together with concerned stakeholders including public health, environmental quality, managed care, education, individual physicians and nurses, hospitals, foundations, families and other colleagues. Become a member of the Arizona Asthma Coalition or renew your membership and help us continue this important work. Join or renew here |
|
|
|
